These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6169957)

  • 21. Beta-blockers in treatment of hypertension.
    Harris D; Richards DA
    Br Med J; 1978 Sep; 2(6141):894. PubMed ID: 30514
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
    Stummvoll HK
    Wien Med Wochenschr Suppl; 1981; 69():14-6. PubMed ID: 6123200
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings of the Second Symposium on Labetalol, London, March 1979.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-244S. PubMed ID: 526409
    [No Abstract]   [Full Text] [Related]  

  • 24. Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
    Lubbe WF; White DA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():283s-286s. PubMed ID: 32006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 27. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Labetalol (Trandate). an antihypertensive agent with both alpha and beta receptor blockading effects].
    Rasmussen S; Andreasen PB
    Ugeskr Laeger; 1980 Mar; 142(13):839-41. PubMed ID: 6102812
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
    Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV
    Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
    Gérard J; Blazquez G; Mounac M; Giraud P; Jeuffroy A; Lardoux H
    Rev Fr Gynecol Obstet; 1984 Nov; 79(11):713-7. PubMed ID: 6152500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings of the Third Symposium on Labetalol.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):1S-141S. PubMed ID: 7093091
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinico-experimental study of the new antihypertensive preparation abletol (labetalol)].
    Glezer GA; Smolenskiĭ VS; Porotikov VI; Meĭler SM; Khodzhamirova VS
    Kardiologiia; 1983 Aug; 23(8):12-6. PubMed ID: 6137588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labetalol in essential hypertension.
    Breckenridge A; Orme M; Serlin MJ; Maciver M
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Labetalol: a new alpha/beta-adrenergic receptor blocking agent].
    Gyimesi A; Hanyecz V; Pocsay G; Iványi J
    Orv Hetil; 1981 Nov; 122(46):2831-4. PubMed ID: 7033885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.